U.S. stocks retreated on Tuesday on lingering media report that Europe would take bold steps to curb its debt crisis, overshadowing an increase in U.S.

By Peter Loftus. The U.S. Food and Drug Administration may take longer than expected to review Pfizer Inc.'s (PFE) application to market a new treatment for rheumatoid arthritis, the drug maker's chief said Tuesday.

(Reuters) - Pfizer Inc <PFE.N> reported higher-than-expected quarterly earnings on Tuesday, due largely to lower spending on research and marketing, and said it may fully divest its animal health unit following an initial public offering of up to 20 ...

On Tuesday July 31, one of the biggest names in the healthcare and drug manufacturing sector, Pfizer (PFE) will report earnings, and expectations are high.

Drug maker Pfizer Inc. (PFE ) on Tuesday posted better-than-expected second quarter earnings results, despite a continued slump in Lipitor cholesterol drug sales amid new generic competition.

By MarketWatch. --Loss of market exclusivity for Lipitor cholesterol drug pressures results. --Second-quarter sales, profit exceed analysts' expectations.

Pfizer Inc. (PFE) (PFE), the world's largest drugmaker, said it will start a filing in mid-August to sell as much as 20 percent of its animal-health unit in an initial public offering.

Pfizer Inc. (PFE), the world's largest drugmaker, said it will start a filing in mid-August to sell as much as 20 percent of its animal-health unit in an initial public offering.